Nissay Asset Management Corp Japan ADV Trims Holdings in Agilent Technologies Inc (A)

Nissay Asset Management Corp Japan ADV cut its holdings in shares of Agilent Technologies Inc (NYSE:A) by 11.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 44,081 shares of the medical research company’s stock after selling 5,621 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Agilent Technologies were worth $3,543,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Findlay Park Partners LLP purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $246,229,000. Norges Bank purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $200,642,000. Oregon Public Employees Retirement Fund increased its position in shares of Agilent Technologies by 6,563.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,338,299 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 2,303,208 shares during the last quarter. Deutsche Bank AG increased its position in shares of Agilent Technologies by 149.2% in the 4th quarter. Deutsche Bank AG now owns 2,569,193 shares of the medical research company’s stock valued at $173,312,000 after purchasing an additional 1,538,352 shares during the last quarter. Finally, Pendal Group Ltd increased its position in shares of Agilent Technologies by 17,076.7% in the 4th quarter. Pendal Group Ltd now owns 1,227,965 shares of the medical research company’s stock valued at $71,925,000 after purchasing an additional 1,220,816 shares during the last quarter.

In other Agilent Technologies news, SVP Michael Tang sold 6,728 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total transaction of $541,604.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Dominique Grau sold 7,711 shares of Agilent Technologies stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $80.00, for a total transaction of $616,880.00. Following the transaction, the insider now directly owns 102,196 shares in the company, valued at $8,175,680. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,329 shares of company stock valued at $4,535,225.

NYSE:A opened at $76.01 on Wednesday. The stock has a market cap of $23.45 billion, a price-to-earnings ratio of 27.24, a price-to-earnings-growth ratio of 2.05 and a beta of 1.33. Agilent Technologies Inc has a twelve month low of $60.42 and a twelve month high of $82.27. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.90% and a net margin of 22.86%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.65 earnings per share. On average, research analysts forecast that Agilent Technologies Inc will post 3.06 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were issued a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, April 1st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.86%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.

Several analysts have recently commented on A shares. UBS Group started coverage on shares of Agilent Technologies in a research note on Friday, March 15th. They issued a “buy” rating and a $92.00 target price for the company. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $79.00 price objective for the company in a research note on Monday, January 21st. JPMorgan Chase & Co. raised their price objective on shares of Agilent Technologies to $85.00 and gave the company an “overweight” rating in a research note on Thursday, February 21st. Bank of America reiterated a “buy” rating and issued a $87.00 price objective (up previously from $78.00) on shares of Agilent Technologies in a research note on Thursday, February 21st. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price objective (up previously from $77.00) on shares of Agilent Technologies in a research note on Monday, February 25th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Agilent Technologies has a consensus rating of “Buy” and an average target price of $87.17.

WARNING: “Nissay Asset Management Corp Japan ADV Trims Holdings in Agilent Technologies Inc (A)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2019/05/15/nissay-asset-management-corp-japan-adv-trims-holdings-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Channel Trading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.